دورية أكاديمية

OA05.03 Single-Agent Rovalpituzumab Tesirine, a Delta-Like Protein 3 (DLL3)-Targeted Antibody-Drug Conjugate (ADC), in Small-Cell Lung Cancer (SCLC)

التفاصيل البيبلوغرافية
العنوان: OA05.03 Single-Agent Rovalpituzumab Tesirine, a Delta-Like Protein 3 (DLL3)-Targeted Antibody-Drug Conjugate (ADC), in Small-Cell Lung Cancer (SCLC)
المؤلفون: Spigel, David, Pietanza, M Catherine, Bauer, Todd, Ready, Neal, Morgensztern, Daniel, Glisson, Bonnie S., Byers, Lauren Averett, Johnson, Melissa, Burris, Howard, Robert, Francisco, Han, Tae, Bheddah, Sheila, Theiss, Noah, Watson, Sky, Mathur, Deepan, Vennapusa, Bharathi, Strickland, Donald, Zayed, Hany, Dylla, Scott, Peng, Stanford, Govindan, Ramaswamy, Rudin, Charles
المصدر: In Journal of Thoracic Oncology January 2017 12(1) Supplement:S260-S261
قاعدة البيانات: ScienceDirect
الوصف
تدمد:15560864
DOI:10.1016/j.jtho.2016.11.252